UPDATE: Retiring Lilly CEO had rough run
Sidney Taurel, Eli Lilly and Co.’s retiring CEO, oversaw the company during a challenging stretch when it lost patent protection for Prozac and faced intense litigation against its blockbuster Zyprexa. Since Taurel became CEO in July 1998, Lilly’s stock price has fallen 17 percent. By comparison, the overall market, as measured by the S&P 500, […]